secwatch.observer — SEC 8-K summary
======================================

Issuer:     Q32 Bio Inc. (QTTB)
CIK:        0001661998
Form:       8-K
Filed at:   2023-06-14T23:59:59+00:00
Accession:  0001193125-23-166857
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Homology Medicines shareholders elect two Class II directors and ratify auditor at annual meeting
--------------------------------------------------------------------------------

- Steven Gillis, Ph.D. elected with 32,246,621 votes for and 2,619,932 withheld; 10,698,943 broker non-votes.
- Albert Seymour, Ph.D. elected with 34,681,867 votes for and 184,686 withheld; 10,698,943 broker non-votes.
- Ratification of Deloitte & Touche LLP as independent auditor approved: 44,765,597 for, 108,239 against, 691,660 abstained.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1661998/000119312523166857/0001193125-23-166857-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1661998/000119312523166857/d285694d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-166857

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer